MRK · News · 20260910N

Revenue Performance and Mix

Merck & Co., Inc. · 2026-09-10 · Importance 18 · Surprise 14 · No source text

Merck reported quarterly revenue of $16.61 billion, exceeding analyst estimates. The quarter also surpassed adjusted earnings forecasts. The reported results included better-than-expected revenue performance despite expectations for a 1.94% year-over-year increase in a forthcoming report.

Key facts

• Analysts anticipate a 12.02% year-over-year decline in Merck & Co., Inc.'s earnings per share for the upcoming report and a projected 1.94% increase in revenue. source
• Merck reported quarterly revenues of $16.61 billion, surpassing estimates. source
• Archford Capital Strategies LLC reduced its stake in Merck & Co., Inc. by 20.4% in the second quarter, holding 27,354 shares valued at $3.52 million. source
• Integrated Wealth Concepts LLC increased its stake in Merck & Co., Inc. by 12.1% in the second quarter, acquiring 13,850 shares and bringing its total holdings to 128,068 shares valued at $16.46 million. source
• Merck has seen insider selling totaling over 228,000 shares in the last 90 days. source
• National Pension Service increased its stake in Merck & Co., Inc. by 0.5% in the second quarter, bringing its total holdings to over 5.79 million shares worth approximately $744.2 million. source
• HSBC raised its price target for Merck & Co., Inc. to $172.00 from $150.00 and maintained a 'buy' rating. source
• Blue Edge Capital LLC purchased 11,499 shares of Merck & Co., Inc., valued at approximately $1.48 million. source

Impact estimates